Author

Payton L. Marshall

Observed names: P L Marshall, Payton L Marshall, Payton Marshall

Institutions: Stanford Medicine, Stanford University

Observed institutions: Stanford Medicine, Stanford University

ORCID: 0000-0002-0921-3016

Observed ORCID: 0000-0002-0921-3016

OpenAlex ID: A5062964305

Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection

2019 · Johanna M. Sweere, Jonas D. Van Belleghem, et al. · Science · 478

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

2022 · Johanna Theruvath, Marie Menard, et al. · Nature Medicine · 249

Hyaluronan in immune dysregulation and autoimmune diseases

2018 · Nadine Nagy, Hedwich F. Kuipers, et al. · Matrix Biology · 91

Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2023 · Miles H. Linde, Amy C. Fan, et al. · Cancer Discovery · 61

4-Methylumbelliferyl glucuronide contributes to hyaluronan synthesis inhibition

2019 · Nadine Nagy, Irina Gurevich, et al. · Journal of Biological Chemistry · 47

The pharmacokinetics and dosing of oral 4-methylumbelliferone for inhibition of hyaluronan synthesis in mice

2016 · H F Kuipers, N Nagy, et al. · Clinical & Experimental Immunology · 43

Modified High-Molecular-Weight Hyaluronan Promotes Allergen-Specific Immune Tolerance

2016 · John A. Gebe, Koshika Yadava, et al. · American Journal of Respiratory Cell and Molecular Biology · 29

Hyaluronan synthesis inhibition impairs antigen presentation and delays transplantation rejection

2020 · Payton L. Marshall, Nadine Nagy, et al. · Matrix Biology · 15

Inhibition of hyaluronan synthesis prevents β-cell loss in obesity-associated type 2 diabetes

2023 · Nadine Nagy, Gernot Kaber, et al. · Matrix Biology · 10

Hymecromone Promotes Longevity and Insulin Sensitivity in Mice

2024 · Nadine Nagy, Kathryn S. Czepiel, et al. · Cells · 6

Anti-GD2 antibody disrupts GD2:Siglec-7 interactions and synergizes with CD47 blockade to mediate tumor eradication

2021 · Johanna Theruvath, Marie Menard, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3

Burden of chronic postsurgical pain after caesarean delivery on maternal quality of life: a systematic review

2026 · Samira Alwahabi, Rebekah Reville Joy, et al. · Anaesthesia · 1

Hyaluronan Accumulates in Inflamed Lymph Nodes and Promotes B‐Cell Activation

2025 · Zhiwei Li, Nadine Nagy, et al. · Proteoglycan Research · 1

Immune dysregulation in uterine atony could suggest new ways to treat postpartum hemorrhage

2026 · Payton Marshall, David Cornfield, et al. · International Journal of Obstetric Anesthesia

Supplemental Figure S3 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Figure S6 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Figure S4 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Figure S8 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Figure S2 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Figure S10 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Figure S1 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Figure S9 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Figure S7 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Table 1 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Supplemental Figure S5 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

2025 · Miles H. Linde, Amy C. Fan, et al.

Works count: 99

Citation count: 1,032

H-index: 9

I10-index: 9